Table 1 Patient sex demographics in FAERS drug cohorts.
From: Common osteoporosis drug associated with increased rates of depression and anxiety
Sex | Alendronate | Zoledronate | Risedronate | Ibandronate | Denosumab | Teriparatide |
|---|---|---|---|---|---|---|
Female | 6,540 | 7,997 | 1,051 | 3,431 | 13,242 | 40,821 |
Male | 757 | 1,145 | 57 | 199 | 1,759 | 3,974 |
Unreported | 524 | 225 | 60 | 97 | 811 | 257 |
Female frequency (%) | 83.6 | 85.3 | 89.9 | 92.1 | 83.7 | 90.6 |
Male frequency (%) | 9.6 | 12.2 | 4.8 | 5.3 | 11.1 | 8.8 |
